These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2021968)

  • 1. Serum-sickness-like illness as a complication after streptokinase therapy for acute myocardial infarction.
    Schweitzer DH; van der Wall EE; Bosker HA; Scheffer E; Macfarlane JD
    Cardiology; 1991; 78(1):68-71. PubMed ID: 2021968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sickness-like illness following streptokinase therapy. A case report.
    Creamer JD; McGrath JA; Webb-Peploe M; Smith NP
    Clin Exp Dermatol; 1995 Nov; 20(6):468-70. PubMed ID: 8857338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.
    Birnbaum Y; Strasberg B; Rechavia E; Neuman Y; Stahl B
    West J Med; 1993 Apr; 158(4):406-9. PubMed ID: 8317134
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum sickness complicating intravenous streptokinase therapy in acute myocardial infarction.
    Alexopoulos D; Raine AE; Cobbe SM
    Eur Heart J; 1984 Dec; 5(12):1010-2. PubMed ID: 6534748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction.
    Davies KA; Mathieson P; Winearls CG; Rees AJ; Walport MJ
    Clin Exp Immunol; 1990 Apr; 80(1):83-8. PubMed ID: 2323103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum sickness after fibrinolysis using intravenous streptokinase in myocardial infarction].
    Albert F; Dubourg O; Steg G; Delorme G; Bourdarias JP
    Arch Mal Coeur Vaiss; 1988 Aug; 81(8):1013-5. PubMed ID: 3144250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinase.
    Patel A; Prussick R; Buchanan WW; Sauder DN
    J Am Acad Dermatol; 1991 Apr; 24(4):652-3. PubMed ID: 1822086
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
    Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L
    N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracerebral hemorrhage and serum sickness after thrombolytic treatment in myocardial infarction].
    Kierkegaard A
    Lakartidningen; 1991 Sep; 88(38):3069-70. PubMed ID: 1921594
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum sickness and purpura following intravenous streptokinase.
    Clesham GJ; Terry HJ; Jalihal S; Toghill PJ
    J R Soc Med; 1992 Oct; 85(10):638-9. PubMed ID: 1433049
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcapsular liver hematoma after fibrinolytic therapy for acute myocardial infarction: a rare case report.
    Safi M; Khaheshi I; Memaryan M; Naderian M
    Acta Biomed; 2016 Jan; 87(3):318-320. PubMed ID: 28112701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral anterior uveitis: a feature of streptokinase-induced serum sickness.
    Proctor BD; Murray PG; Joondeph BC
    N Engl J Med; 1994 Feb; 330(8):576-7. PubMed ID: 8302336
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunology of a serum sickness/vasculitis reaction secondary to streptokinase used for acute myocardial infarction.
    Davidson JR; Bush RK; Grogan EW; Boh LA; Graziano FM
    Clin Exp Rheumatol; 1988; 6(4):381-4. PubMed ID: 3229027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse pulmonary hemorrhage after fibrinolytic therapy for acute myocardial infarction.
    Masip J; Vecilla F; Páez J
    Int J Cardiol; 1998 Jan; 63(1):95-7. PubMed ID: 9482153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of cholesterol embolization syndrome after intravenous streptokinase for acute myocardial infarction.
    Queen M; Biem HJ; Moe GW; Sugar L
    Am J Cardiol; 1990 Apr; 65(15):1042-3. PubMed ID: 2327344
    [No Abstract]   [Full Text] [Related]  

  • 16. Lingual hematoma due to streptokinase in a patient with acute myocardial infarction.
    Kaya A; Ordu S; Albayrak ES; Aydin M; Erden I; Ozhan H
    Am J Emerg Med; 2010 Oct; 28(8):985.e1-2. PubMed ID: 20825845
    [No Abstract]   [Full Text] [Related]  

  • 17. Microembolism from aortic aneurysm and ventricular thrombus: a complication of intravenous streptokinase.
    Abraham JS; Wilson M; Scripcariu V; Barnes PC; Marcuson RW
    Postgrad Med J; 1994 Oct; 70(828):756-8. PubMed ID: 7831178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atheromatous material mobilization syndrome after thrombolytic therapy with streptokinase in acute myocardial infarct].
    Arpesani A; Beretta L; Giorgetti PL; Varesi C; Matturri L
    Minerva Cardioangiol; 1991 Jun; 39(6):251-4. PubMed ID: 1961445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous pulmonary hemorrhage after thrombolytic therapy for acute myocardial infarction.
    Awadh N; Ronco JJ; Bernstein V; Gilks B; Wilcox P
    Chest; 1994 Nov; 106(5):1622-4. PubMed ID: 7956438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cholesterol embolization after intravenous streptokinase therapy in acute myocardial infarction].
    Bucher A; Roald B
    Tidsskr Nor Laegeforen; 1993 Jun; 113(15):1844-5. PubMed ID: 8322322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.